It targets the Sonic hedgehog (SHH) signaling pathway by inhibiting SHH ligand secretion, disrupting the cytoskeleton, and downregulating the expression of PTCH2, SUFU, and Gli1, thereby directly blocking the ability of GC cells to form VM (Zang et al., 2021). This evidence concerns the gene SHH and gastric cancer.